Chronic Kidney Disease Flashcards

(39 cards)

1
Q

Spectrum of pathophysiologic processes associated with abnormal kidney function and a progressive decline in glomerular filtration rate (GFR)

A

Chronic Kidney Disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

2 Broad Sets of Mechanisms of Damage in CKD

A
  1. initiating mechanisms specific to the underlying etiology

2. hyperfiltration and hypertrophy of the remaining viable nephrons

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Risk Factors of CKD

A
  • small for gestation birth weight
  • childhood obesity
  • hypertension
  • diabetes mellitus
  • autoimmune disease
  • advanced age
  • African ancestry
  • a family history of kidney disease
  • a previous episode of acute kidney injury and presence of proteinuria
  • abnormal urinary sediment
  • structural abnormalities of the urinary tract
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Normal annual mean decline in GFR with age from the peak GFR (~120 mL/min per 1.73 m2) attained during the 3rd decade of life

A

~1 mL/min per year per 1.73 m2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Refers to the excretion of amounts of albumin too small to detect by urinary dipstick or conventional measures of urine protein

A

Microalbuminuria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Serves as a marker not only for early detection of primary kidney disease, but for systemic microvascular disease as well

A

urinary albumin to creatinine ratio (UACR)

MEN - > 17 mg albumin/g creatinine
WOMEN - > 25 mg albumin/g creatinine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Devised to predict the risk of progression to stage 5 dialysis-dependent kidney disease

A

Kidney Failure Risk (KFR) equation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Factors affecting the likelihood and rate of CKD progression

A

baseline eGFR and degree of albuminuria
primary renal disease
ongoing exposure to nephrotoxic agents
others: obesity, hypertension, age, ethnicity and laboratory parameters

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Stage of CKD where the accumulation of toxins, fluid, electrolytes normally excreted by the kidney –> uremic syndrome

A

ESRD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Etiologies of CKD

A
Diabetic nephropathy
Glomerulonephritis
HPN associated CKD
ADPKD
Other cystic and tubulointerstitial nephropathy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Major risk factor for cardiovascular disease

A

Minor decrement in GFR or the presence of albuminuria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

PATHOPHYSIOLOGY OF UREMIC SYNDROME (3 Spheres Of Dysfunction)

A
  1. accumulation of toxins that normally undergo renal excretion
  2. loss of other kidney functions such as fluid and electrolyte homeostasis and hormone regulation
  3. progressive systemic inflammation and its vascular and nutritional consequences
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

May serve as an indication to initiate dialysis in advanced CKD

A

diuretic resistance with intractable edema and hypertension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Common disturbance in advanced CKD – metabolic acidosis

A

NAGMA – early stage

HAGMA – later stage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Used to maintain euvolemia in CKD

A

dietary salt restriction and loop diuretics + metolazone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Treatment of hyperkalemia in CKD

A

dietary restriction of potassium
Kaliuretic diuretics
potassium-binding resins – calcium resonium, sodium polystyrene or patiromer

17
Q

Considered a uremic toxin and high levels are associated with muscle weakness, fibrosis of cardiac muscle, and nonspecific constitutional symptoms

A

parathyroid hormone

18
Q

Leading cause of morbidity and mortality in patients at every stage of CKD

A

cardiovascular abnormalities

19
Q

Cardiovascular abnormalities

A

Ischemic Vascular Disease
Heart Failure
Hypertension and Left Ventricular Hypertrophy
Pericardial Disease

20
Q

For the CKD patient not yet on dialysis or the patient treated with peritoneal dialysis

A

oral iron supplementation

21
Q

Subtle clinical manifestations of uremic NEUROMUSCULAR disease usually become evident at

22
Q

PERIPHERAL NEUROPATHY becomes clinically evident after the patient reaches

23
Q

EARLY MANIFESTATIONS OF CNS COMPLICATIONS:

A

mild disturbances in memory and concentration and sleep disturbance

24
Q

LATER STAGES:

A

neuromuscular irritability – hiccups, cramps, and twitching

25
ADVANCED UNTREATED KIDNEY FAILURE
asterixis myoclonus seizures coma
26
Characterized by ill-defined sensations of sometimes debilitating discomfort in the legs and feet relieved by frequent leg movement
“restless leg syndrome”
27
Urine-like odor on the breath, derives from the breakdown of urea to ammonia in saliva and is often associated with an unpleasant metallic taste (dysgeusia)
uremic fetor
28
Quite common and one of the most vexing manifestations of the uremic state
pruritus
29
Skin condition unique to CKD patients which consists of progressive subcutaneous induration, especially on the arms and legs
nephrogenic fibrosing dermopathy
30
Diagnosis of CKD of long-standing duration
bilaterally small kidneys ``` EXCEPTION: diabetic nephropathy amyloidosis HIV nephropathy polycystic kidney disease ```
31
COMMONLY ACCEPTED CRITERIA FOR INITIATING PATIENTS ON MAINTENANCE DIALYSIS
• presence of uremic symptoms nausea, vomiting, anorexia altered mental status – lethargy, somnolence, malaise, stupor, coma, delirium pericarditis friction rub chest pain dyspnea bleeding diathesis uremic encephalopathy – asterixis (flapping tremor of the hand), tremor multifocal myoclonus, seizures uremic fetor (breath smells like urine) sallow skin (slightly yellow and/or slightly pale) * presence of hyperkalemia unresponsive to conservative measures * persistent extracellular volume expansion despite diuretic therapy * acidosis refractory to medical therapy * bleeding diathesis * creatinine clearance or estimated glomerular filtration rate (GFR) <10 mL/min per 1.73 m2)
32
Relies on the principles of solute diffusion across a semipermeable membrane, movement of metabolic waste products takes place down a concentration gradient from the circulation into the dialysate
Hemodialysis
33
3 essential components to hemodialysis
dialyzer composition and delivery of the dialysate blood delivery system
34
Have the highest long-term patency rate of all hemodialysis access options
Fistula
35
The most common additives to peritoneal dialysis solutions
heparin
36
dialysis access is the preferred option if your veins are too small
AV graft
37
Absolute Indications for Renal Replacement Therapy
Pericarditis or Pleuritis Progressive Uremic Encephalopathy or neuropathy w/ signs such as confusion, asterixis, myoclonus, wrist or foot drop, seizures Bleeding diathesis attributable to uremia Persistent metabolic disturbances that are refractory to medical therapy - hyperkalemia, metabolic acidosis, hypercalcemia, hypocalcemia and hyperphosphatemia Fluid overload refractory to diuretics HPN poorly responsive to antiHPN medications Persistent nausea and vomiting Evidence of malnutrition
38
Relative Indications for Renal Replacement Therapy
anorexia and nausea impaired nutritional status increased sleepiness decreased energy levels, attentiveness and cognitive tasking
39
Indication for Maintenance Dialysis
Uremic Symptoms - N/V, loss of consciousness, uremic pericarditis Intractable HYPERKALEMIA Persistent Volume Expansion despite Diuretics Refractory ACIDOSIS Bleeding Diasthesis eGFR < 1.73 mL